Next Article in Journal
Thermal, Mechanical, and Rheological Properties of Biocomposites Made of Poly(lactic acid) and Potato Pulp Powder
Next Article in Special Issue
Temporal Splicing Switches in Elements of the TNF-Pathway Identified by Computational Analysis of Transcriptome Data for Human Cell Lines
Previous Article in Journal
Lipid Headgroup Charge and Acyl Chain Composition Modulate Closure of Bacterial β-Barrel Channels
Previous Article in Special Issue
TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis
Open AccessReview

Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity

Department of Medicine – DIMED, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 676; https://doi.org/10.3390/ijms20030676
Received: 12 December 2018 / Revised: 23 January 2019 / Accepted: 31 January 2019 / Published: 5 February 2019
(This article belongs to the Special Issue Tumor Necrosis Factor (TNF))
Systemic and local chronic inflammation might enhance the risk of pancreatic ductal adenocarcinoma (PDAC), and PDAC-associated inflammatory infiltrate in the tumor microenvironment concurs in enhancing tumor growth and metastasis. Inflammation is closely correlated with immunity, the same immune cell populations contributing to both inflammation and immune response. In the PDAC microenvironment, the inflammatory cell infiltrate is unbalanced towards an immunosuppressive phenotype, with a prevalence of myeloid derived suppressor cells (MDSC), M2 polarized macrophages, and Treg, over M1 macrophages, dendritic cells, and effector CD4+ and CD8+ T lymphocytes. The dynamic and continuously evolving cross-talk between inflammatory and cancer cells might be direct and contact-dependent, but it is mainly mediated by soluble and exosomes-carried cytokines. Among these, tumor necrosis factor alpha (TNFα) plays a relevant role in enhancing cancer risk, cancer growth, and cancer-associated cachexia. In this review, we describe the inflammatory cell types, the cytokines, and the mechanisms underlying PDAC risk, growth, and progression, with particular attention on TNFα, also in the light of the potential risks or benefits associated with anti-TNFα treatments. View Full-Text
Keywords: anti-TNFα; cytokines; inflammation; miRNA; myeloid derived suppressor cells; pancreatic cancer; S100A8; S100A9; TNFα; Treg lymphocytes; tumor associated macrophages anti-TNFα; cytokines; inflammation; miRNA; myeloid derived suppressor cells; pancreatic cancer; S100A8; S100A9; TNFα; Treg lymphocytes; tumor associated macrophages
Show Figures

Figure 1

MDPI and ACS Style

Padoan, A.; Plebani, M.; Basso, D. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity. Int. J. Mol. Sci. 2019, 20, 676. https://doi.org/10.3390/ijms20030676

AMA Style

Padoan A, Plebani M, Basso D. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity. International Journal of Molecular Sciences. 2019; 20(3):676. https://doi.org/10.3390/ijms20030676

Chicago/Turabian Style

Padoan, Andrea; Plebani, Mario; Basso, Daniela. 2019. "Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity" Int. J. Mol. Sci. 20, no. 3: 676. https://doi.org/10.3390/ijms20030676

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop